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Introduction
The loss of retinal ganglion cells (RGCs) is a consistent feature of the ageing mammalian visual system, which is thought to contribute to the age-related decline in visual function (Sanchez et al., 1986; Jonas et al., 1989; Jonas et al., 1990; Morrison et al., 1990; Harman et al., 2000; Neufeld and Gachie, 2003) . The role of apoptosis in the elimination of RGCs in ageing and retinal pathology has been well documented (Spear, 1993; Quigley et al., 1995; Cecconi et al., 1998; Neufeld and Gachie, 2003) . Recent work in the ageing and age related diseases such as glaucoma suggest that RGCs undergo a prolonged process of degeneration prior to elimination from the RGCL manifest as reduction in the complexity of the dendritic tree and the elimination of terminal processes (Watts et al., 2003; Whitmore et al., 2005; Williams et al., 2006; Kisiswa et al., 2009 ). These observations are consistent with those in other neuronal systems where parts of the neuron degenerate at different rates raising the possibility that during the early stages of degeneration, neuronal damage is associated with partial activation of programmed cell death (Whitmore et al., 2005) .
We have recently proposed that these chronic changes in neuronal morphology indicate a balance between the factors that initiate program cell death and those that inhibit the process . In support of this suggestion there is evidence that caspase activation, which is a consistent trigger to apoptosis is countered by IAPs, whose expression and activation increases in the cells that are entering the apoptosis process ). To date, 8 mammalian IAPs have been identified: NIAP, cIAP1 and 2, XIAP, Survivin, Bruce, Livin and testis IAP (tIAP). IAPs arrest apoptosis by binding directly to caspases through their BIR domains, thereby preventing caspase activation and activity (Liston et al., 2003) .
It has been shown that cIAP1 inhibits apoptosis through its association with TRAF2, which, in turn, builds a multicomplex with cIAP2 and TRAF3 (Rothe et al., 1995) .
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There is evidence that cIAP1 binds to TRAF2 leading to ubiquitin-dependent degradation of TRAF2 (Rothe et al., 1995; Chu et al., 1997; Tang et al., 2003) and is a consequence of signalling through TNFR 2 (TNFRII) functioning as a feedback signal for activation of the nuclear factor kappa B (NF-κB) signalling pathway . Upon activation of TNFR1 and/or 2, TRAF 2 builds a multicomplex with cIAP1, 2 and TRAF3 leading to activation of survival pathways, namely, NF-κB and Jun NH 2 -terminal Kinase (JNK) (Rothe et al., 1995; Eckelman and Salvesen, 2006) . Furthermore, TRAF2 interacts with TRADD leading to NF-κB activation (Hsu et al., 1995; Hsu et al., 1996; Shu et al., 1996) suggesting that TRAF2 is involved in both TNF-R1 and TNF-R2-mediated NF-kB activation. Moreover, recent work provides emerging evidence of a role for NFkB activity in ageing as a key mechanism restraining oxidative stress in immune cells and contributing to longevity (Arranz et al., 2010) .
In this study, to better understand the relationship between caspase activation and inhibition during retinal maturation, we therefore determined the expression profile of caspases, IAPs and TRAF2 expression in uncompromised young adult and mature BN rat retina. The analysis was performed in the whole retina and in isolated retinal ganglion cell layer (RGCL) preparation.
Methods
Animal husbandry
All samples were taken from male BN rats in the following age groups: young adults (male, age 6 weeks), adults (male, age 10 and 16 weeks) and mature (male, age >24 weeks (range 24 to 52 weeks)). Animals were maintained on a rodent global diet pellet (Harlan, UK) and given water ad libitum. Experiments were conducted in accordance with Home Office (UK) regulations and ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Total retinal RNA isolation and semi-quantitative RT-PCR
The eyes of 6, 10, 16 and >24 weeks rats were enucleated and the anterior segment, vitreous body and sclera removed. Total RNA from 6 animals per age group was isolated using Qiagen RNAeasy mini kit (Qiagen, West Sussex,UK) from the dissected retinae according to manufacture's instructions. Following DNase1 (Qiagen, West Sussex, UK) digestion of RNA using 1 unit DNase/µg at room temperature for 30 minutes. 500ng RNA was reverse transcribed to cDNA using reverse transcriptase kit and Oligo dT (BIOLINE, London, UK) according to the manufacturer's instructions. The cDNA was amplified using 0.025 U/µl of Taq polymerase (Qiagen, West Sussex, UK). Initial reactions were performed to determine the annealing temperatures and duration of product elongation. All products were optimized for cycle number. The conditions were chosen so that all of the genes analysed were in the exponential phase of amplification. The primers (Sigma-Aldrich, Dorset, UK) were designed to span intron-exon boundaries (see Table 1 ) using the Primers3 programme (http://frodo.wi.mit.edu/primer3/) and used at a concentration of 0.25µM, unless indicated.
No-RT controls were included in the study to ensure that the primers were not amplifying genomic DNA. Each experiment was carried out three times. PCR products were separated on a 1.5% agarose gel containing ethidium bromide (Promega, Hampshire, UK) and visualized under UV light in (UVP-Bio Doc-It TM Systems, Cambridge, UK). Densitometry was performed using ImageMaster 1D prime (Pharmacia Biotechnologies Inc, San Francisco, USA). The semi-quantitative RT-PCR method used was similar to that we described previosuly (Geatrell et al., 2009) . For each gene, the number of cycles used for each set of primers was based on initial experiments in which the number of PCR cycles was varied such that, for all genes, the PCRs were in the linear part of the PCR amplification curve. 
Retinal Shaving
Retinal shaving was performed as previously described (Sokolov et al., 2002) . Briefly, retinal flat-mount was transferred with ganglion cell side up to a millicell nitrocellulose insert three washes in TBST, membranes were incubated in appropriate peroxidase-linked secondary antibodies (1.5000; Santa Cruz, Heidelberg, Germany) for 1h before substrate development using ECL-plus (GE Healthcare, Bucks, UK). Laser scanning densitometry was performed and bands were quantified using Labworks programme (UV BioImaging Systems, Cambridge, UK).
Immunofluoroscence analysis
Eye-cups (anterior segment and lens removed) were wax embedded as standard and serially sectioned at 7 µm. They were then de-waxed, washed in PBS and blocked with 5% rabbit serum in PBS containing 0.01% Triton x 100 (Sigma-Aldrich, Dorset, UK) for 1h at room temperature. Tissues were incubated overnight at 4 o C with primary antibody in 1% rabbit serum (anti-active caspase 3 (polyclonal, 1µg, Abcam, Cambridge, UK), anti-cIAP1
(polyclonal, 1:200; Santa Cruz, Heidelberg, Germany) and anti-TRAF2 (polyclona, 1:100; Santa Cruz, Heidelberg, Germany). After three washes, the sections were incubated with Alexa-Flour-labeled secondary antibody (1:1000, Invitrogen, Paisley, UK) for 2h at room temperature. All sections were counterstained with To-PRO 3 (Invitrogen, Paisley, UK) and mounted using Hydro-mount solution (National Diagnostic, England, UK). Controls (secondary antibody alone) were included in all studies. Sections were imaged using an Axioplan Zeiss laser scanning confocal microscopy (Zeiss, Heidelberg, Germany) equipped with different filters; absorption at 494nm and emission 518nm filter, absorption at 555 nm and emission 575 filter for Alexa fluor (488nm) and (546nm), respectively and absorption 640 nm and emission 690 filter for To-PRO3. Staining intensity was quantified utilising Adobe Photoshop (Adobe Systems Incorporated, Uxbridge, UK) and expressed as percentage of the staining intensity of the experimental sections after extracting the background staining intensity.
Statistical analysis
Data were expressed as mean and standard errors. Following normality testing, group comparisons were made using independent student t-test (SPSS16, Chicago, Illinois) or oneway ANOVA as appropriate followed by Fisher's Turkey's post hoc test (SPSS16, Chicago, Illinois). Differences were considered significant for p< 0.05.
Results
Caspase and IAP mRNA expression in the whole retina
No statistical significant change in mRNA levels of caspases 3,6,7,8 and 9 (Fig, 1A) or IAP (NIAP, cIAP2, XIAP, Survivin, Bruce and Livin) were identified between 6 and >24 weeks old retinae with the exception of cIAP1 (Fig. 1B) . cIAP1 mRNA levels were significantly down-regulated in mature retinae when compared to younger retinae (p<0.001). Real-time PCR (Fig. 2 ) demonstrated a statistical significant (p<0.001) gradual reduction among the groups in cIAP1 levels during maturation of the BN rat retina through the stages examined.
cIAP1 was significantly down-regulated at the protein level.
Levels of cIAP1 protein in whole retinal lysate were modest but statistically significantly reduced (p=0.040) in mature compared to younger retina ( Fig. 3A-B ). cIAP1 protein levels were then determined in isolated RGCL shave samples. The purity of the RGCL shaves was confirmed by immunoblotting for the RGC marker (Thy 1) and bipolar marker (Chx 10).
Staining for Thy-1 was more intense and the Chx 10 was absent in the RGCL lysate compared to the non-GCL lysate (Fig.4A ) confirming precise isolation of the cells in RGCL. Expression of cIAP1 protein in the non-RGCL remained constant (Fig. 4B-C ) while cIAP1 protein amounts were statistically significantly decreased (p=0.023) (Fig. 4D-E ) in the mature compareded to younger animals in the RGCL. Immunofluoroscence analysis confirmed the absence of expression of cIAP1 protein in mature RGCL (Fig. 5A-D) .
Down-regulation of cIAP1 is not associated with modulation of caspase 3 activity
Western blotting analysis of active caspase 3 in whole retinal lysate showed no difference in the levels of active caspase 3 between the ages studied ( Fig. 6A-B) . Immunofluoroscence M A N U S C R I P T
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Accumulation of TRAF2 in RGCL
Immunoblotting for TRAF2 in retinae with reduced cIAP1 demonstrated that an accumulation of TRAF2 protein in these retinae with age ( Fig. 7A-B ), but this did not reach statistical significance. The trend indicating an increase in TRAF2 protein was confirmed with immunofluoroscence analysis, which revealed statistically significant (p=0.018) accumulation of TRAF2 in mature retinae ( Fig. 7C-F) . Comparison in TRAF2 expression between non-RGCL and RGCL showed consistent TRAF2 expression in non-RGCL lysate ( Fig. 8A-B ).
TRAF2 expression in RGCL lysate was significantly (p=0.011) elevated ( Fig. 8C-D) .
Discussion
Current research has focused on understanding the molecular mechanisms underlying neurodegenerative diseases, including retinal degeneration and normal maturation and ageing, to identify molecules that could represent targets for therapeutic intervention. There is compelling evidence that the expression of apoptotic factors is altered during neurodegenative diseases and ageing (McKernan et al., 2006; Kisiswa et al., 2009) . In this study, we provide evidence that expression of IAPs is generally reduced during maturation of BN rat retina with a marked reduction in the expression of cIAP1. Expression of active caspase 3 remains unchanged during retinal maturation. Moreover, we demonstrated accumulation of TRAF2 in mature retina accompanying the reduction in cIAP1 expression.
Previous studies have shown, in contrast to the present report that caspase 3 expression is significantly reduced during development and early maturation of the mouse retina between p6 and p60 (McKernan et al., 2006) . It is possible that species-specific M A N U S C R I P T
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11 difference in caspase 3 expression could be responsible for this apparent difference. A more likely explanation is that the difference is due to the different ages examined in the two studies; our study examined animals at 6 weeks at the earliest stage and did not include animals as young as P6, where we would expect to see changes in caspase activity arising during development (Silver and Hughes, 1973; Silver and Robb, 1979) .
We have shown that IAP expression is generally decreased in mature (>24 weeks) compared to younger retinae (6-16 weeks), suggesting that inhibition of apoptosis signalling is compromised during maturation, which could help to explain why neuronal degeneration is a common feature during ageing. Although it is still unclear whether the IAP expression pattern in human retina varies during ageing, we propose that our observations in rats are important for understanding the molecular mechanism underlying RGC cell death in human ageing and glaucoma. This is because the most used model for human glaucoma is the rat. In particular, cIAP1 was significantly down-regulated both at the mRNA and protein level and down-regulation was specific for cells in the RGCL ,suggesting impairment in activation of survival pathways specifically in these cells and that it was associated with maturation.
Changes in cIAP1 would impact the vulnerability of cells to external insults. For age related diseases such as glaucoma, we would anticipate that RGCs would be more vulnerable to damage simply as a function of age and in increased susceptibility to the initiation of apoptosis. Our observations are consistent with those reporting increased vulnerability to RGC and axon damage in the ageing rat (Cepurna et al., 2005) . Caution should be exercised when determining the effects of IOP on the treated eye that note is taken of the age at which ocular hypertension is induced. It is also likely that studies on cultured RGCs taken from younger eyes (e.g. P6) may not provide the full picture for RGC susceptibility in disease. For instance, RGCs in culture seems to be particularly susceptible to hypoxia and excitotoxic damage but this is not the case in vivo Kitano et al., 1996) .
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
12
We did not observe any alteration in caspase 3 activity as a consequence of reduced cIAP1 expression. Early reports on cIAP1 and 2, suggest that these proteins protect cells against apoptotic signals through binding to caspases via their BIR domains (Orth and Dixit, 1997; Roy et al., 1997; Clem, 2001; Shiozaki and Shi, 2004) . However, our observations are consistent with recent work demonstrating that, although cIAP1 is capable of binding caspases, it does not inhibit their activity (Eckelman and Salvesen, 2006) , suggesting that during evolution the cIAP1 BIR domains that interact with caspases have lost the protease inhibition sequence, which is found in other IAPs such as XIAP. Consistent with this, our data support the notion that cIAPs inhibit apoptosis by enhancing activation of survival pathways.
We observed accumulation of TRAF2 in the RGCL during maturation of the rat retina suggesting that the reduction of cIAP1 expression that we observe might lead to impairment in NF-κB survival signalling, thereby facilitating apoptotic activity. Since we observed no significant alteration in active caspase expression in our studies, it is possible that activation of caspase-independent apoptosis also occurs in RGCs during maturation. Indeed, several groups have shown that caspase-independent cell death occurs in adult neurons (Okuno et al., 1998; Selznick et al., 2000; Zhang et al., 2002) . Other types of cell death such as, autophagy, dark cell death and parapoptosis have been suggested to occur in glaucoma (Turmaine et al., 2000; Sperandio et al., 2004; Whitmore et al., 2005; Nixon, 2006; .
Whilst this study demonstrates a reduction in the expression of cIAP1 in the RGCL of mature BN retina, it is still unclear at present to what degree cIAP1 contributes to the death of the cells in the RGCL, importantly RGC death. Indeed, we have recently examined the morphological changes in retinal cell populations, along with the number, density and architectural structure of neurons in young adult and mature BN rat retina M A N U S C R I P T
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13 (Kisiswa et al., unpublished) . In these studies, we observed no cell loss in the retina during the ages we studied, which were similar to those examined here. Although there was an initial reduction in cell density observed, this was shown to be due to retinal expansion. What we actually observed was compromised RGC morphology -a moderate, but significant reduction in dendritic complexity. Therefore, it is important to determine the magnitude of cIAP1 contribution to RGC death and also possibly dendrite remodelling (as we recently suggested; Kisiswa et al., 2010) in functional studies, which will tell us more about the signalling mechanisms involved.
As already demonstrated by several groups, cIAP1 seems to be a common player in inducing cell death and activation of survival pathways (Hsu et al., 1995; Rothe et al., 1995; Hsu et al., 1996; Shu et al., 1996; Eckelman and Salvesen, 2006) . Furthermore, there is evidence that exogenous IAPs may protect neurons during glaucoma. Gene therapy delivery of XIAP/BIRC4 to the retinae of chronical ocular hypertensive (COH) model of rat glaucoma significantly promoted optic nerve axon survival (Kugler et al., 1999; Kugler et al., 2000; McKinnon et al., 2002) .
In summary, we have shown that cIAP1 is statistically significantly down- 
